Stelara

Evernorth Will Offer a Private-Label Stelara Biosimilar in 2025
Managed Healthcare Executive
Thu, 09/5/24 - 10:32 pm
Evernorth Health
Stelara
biosimilars
Janssen
JNJ
J&J's bid to change pay model for Stelara, Xarelto slammed
Pharmaphorum
Mon, 08/26/24 - 10:16 am
JNJ
Stelara
340B
Xarelto
IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Samsung Bioepis Gets FDA Approval for Biosimilar of J&J’s Stelara
BioSpace
Mon, 07/1/24 - 09:58 pm
Samsung Bioepis
FDA
Pyzchiva
biosimilars
JNJ
Stelara
Colorado drug review board finds J&J's Stelara unaffordable, teeing up potential statewide price cap
Fierce Pharma
Tue, 06/11/24 - 11:20 am
Colorado
JNJ
Stelara
drug pricing
J&J Positions Tremfya as Stelara Successor with Strong Head-to-Head Data
BioSpace
Wed, 05/22/24 - 11:33 am
JNJ
Tremfya
Stelara
Crohn's Disease
With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US
Fierce Pharma
Thu, 02/29/24 - 06:57 pm
JNJ
Stelara
biosimilars
Biocon Biologics
J&J focuses on newer meds to offset Stelara patent cliff
BioPharma Dive
Wed, 01/24/24 - 10:52 am
JNJ
Stelara
patents
patent cliff
Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar
BioSpace
Thu, 11/30/23 - 11:20 pm
Samsung Bioepsis
JNJ
patents
Stelara
biosimilars
SB17
HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations
BioSpace
Tue, 11/7/23 - 09:48 am
JNJ
Stelara
HHS
Inflation Reduction Act
Medicare
drug pricing
Amgen scores FDA approval for Stelara biosimilar
Pharmaceutical Technology
Wed, 11/1/23 - 10:16 pm
Amgen
Stelara
biosimilars
JNJ
FDA
Wezlana
AbbVie trumpets Skyrizi's resounding win against J&J's Stelara in Crohn's disease
Fierce Pharma
Mon, 10/16/23 - 11:50 am
AbbVie
Akyrizi
JNJ
Stelara
Crohn's Disease
FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue
BioSpace
Thu, 10/12/23 - 10:22 am
Alvotech
AVT04
JNJ
Stelara
biosimilars
FDA
AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial
BioSpace
Wed, 09/13/23 - 11:36 am
AbbVie
Skyrizi
JNJ
Stelara
Crohn's Disease
clinical trials
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
BioSpace
Tue, 09/12/23 - 10:40 am
Sandoz
Samsung Bioepis
biosimilars
JNJ
Stelara
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
patent cliff
patents
Takeda
Vyvanse
Pfizer
Eraxis
JNJ
Stelara
Merck
Isentress
Eiger Pharmaceuticals
Zokinvy
Astellas
Myrbetriq
Novartis
Entresto
Amgen
Otzela
J&J's Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal
Fierce Pharma
Mon, 08/7/23 - 10:52 am
JNJ
Stelara
patents
legal
Formycon
Fresenius Kabi
Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva
Fierce Pharma
Mon, 06/12/23 - 11:36 pm
JNJ
Stelara
biosimilars
legal
patents
Teva Pharmaceutical
Alvotech
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
Thu, 06/1/23 - 11:41 am
AstraZeneca
IBD
AbbVie
JNJ
brazikumab
Skyrizi
Stelara
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
Tue, 05/23/23 - 06:14 pm
JNJ
Amgen
patents
Stelara
biosimilars
legal

Pages